A Randomized,Double-blind,Vehicle-controlled, Parallel-design,Multiple-site Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% (Douglas Pharmaceuticals America Ltd) to Ketoconazole Cream 2% (Teva Pharmaceuticals USA Inc.) in the Treatment of Tinea Pedis.
Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis.
100 Clinical Results associated with Douglas Pharmaceuticals America Ltd.
0 Patents (Medical) associated with Douglas Pharmaceuticals America Ltd.
100 Deals associated with Douglas Pharmaceuticals America Ltd.
100 Translational Medicine associated with Douglas Pharmaceuticals America Ltd.